New ETF Book by Larry Connors - Click here to read more
-- Jun 25, 2009 Generex Biotechnology Corporation (Nasdaq:GNBT) closed at $0.56 on a volume of 3,951,944 shares.
Generex's New Vaccine Technology Could Speed Flu Vaccine Availability
WORCESTER, Mass., Jun 26, 2009 -- Antigen Express Inc., a wholly owned subsidiary of Generex Biotechnology Corporation (Nasdaq:GNBT), has developed new vaccine technology that "could rapidly lead to safe, effective flu vaccines," according to a June 23, 2009 article in the Worcester, Massachusetts Telegram & Gazette.
"It's not a biological process, it's a chemical process," explained Douglas M. Powell, PhD, director of immunobiology at Antigen Express. "It's not futuristic, it's here now."
About Generex Biotechnology Corporation
Generex is engaged in the research, development and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist(tm) device. The Company's flagship product, oral insulin (Generex Oral-lyn(tm)), which is available for sale in India and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world. For more information, visit the Generex website at http://www.generex.com.
-- Jun 25, 2009 Align Technology, Inc. (Nasdaq: ALGN | Quote | Chart | News | PowerRating) closed at $10.82 on a volume of 521,543 shares.
Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation
SANTA CLARA, Calif., June 26, 2009 -- Align Technology, Inc. (Nasdaq: ALGN | Quote | Chart | News | PowerRating) today announced that a jury delivered a verdict against Align in a lawsuit brought by Ormco Corporation (Ormco) against Align Technology, Inc. (Align) in the U.S. District Court for the Central District of California (District Court). Ormco alleged that Align infringed claims of Ormco's 6,616,444 patent. Align claimed non-infringement, invalidity, as well as unenforceability of the patent.
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.
-- Jun 25, 2009 Novavax, Inc. (Nasdaq: NVAX | Quote | Chart | News | PowerRating) closed at $2.51 on a volume of 964,847 shares.
Novavax Appoints Stanley Erck to Board of Directors
ROCKVILLE, Md., June 26, 2009 -- Novavax, Inc. (Nasdaq: NVAX | Quote | Chart | News | PowerRating) announced today the appointment of Stanley Erck to the company's Board of Directors. Mr. Erck has more than twenty five years of experience in the biotechnology and health-care industries and served most recently as President and Chief Executive Officer of Iomai Corporation, a developer of vaccines and immune system therapies that was acquired in 2008 by Intercell. Previously, Mr. Erck was President and Chief Executive Officer of Procept, a publicly traded immunology company, Vice President of Corporate Development at Integrated Genetics (now Genzyme), and in management positions at Baxter International. His appointment brings the number of Novavax board members to nine.
ABOUT NOVAVAX
Novavax, Inc. (Nasdaq: NVAX | Quote | Chart | News | PowerRating) is a clinical-stage biotechnology company creating novel vaccines, including H1N1, to address a broad range of infectious diseases worldwide using advanced proprietary virus-like-particle (VLP) technology. The company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission.
-- Jun 25, 2009 Omniture, Inc. (NASDAQ: OMTR | Quote | Chart | News | PowerRating) closed at $12.80 on a volume of 532,423 shares.
Improvement Direct Increases Web Site Revenue With Omniture Test&Target(TM)
Home Improvement Retailer Recovers Lost Revenue Through Testing; Increases Revenue per Visitor and Average Order Value With Streamlined Payment Options
OREM, UT, Jun 26, 2009 -- Omniture, Inc. (NASDAQ: OMTR), a leading provider of online business optimization software, today announced that Improvement Direct, a leading home improvement retailer, is using Omniture Test&Target(TM) together with Omniture SiteCatalyst to improve the performance of its network of ecommerce Web sites. Improvement Direct selected Omniture Test&Target for its ability to conduct unlimited A/B and multivariate testing from one single application and tie directly into its analytics application, SiteCatalyst. After running several A/B and multivariate tests on its site with Test&Target, the retailer was able to recover lost revenue related to restocking costs and also increased revenue per visitor (RPV) by nearly 33 percent and average order value (AOV) by almost 38 percent.
About Omniture Omniture, Inc. is a leading provider of online business optimization software, enabling customers to manage and enhance online, offline and multi-channel business initiatives. Omniture's software, which it hosts and delivers to its customers as an on-demand subscription service and on-premise solution, enables customers to capture, store and analyze information generated by their Web sites and other sources and to gain critical business insights into the performance and efficiency of marketing and sales initiatives and other business processes. In addition, Omniture offers a range of professional services that complement its online services, including implementation, best practices, consulting, customer support and user training through Omniture Education. Omniture's nearly 5,200 customers include eBay, AOL, Wal-Mart, Gannett, Microsoft, Neiman Marcus, Oracle, Sony and HP.www.omniture.com
-- Jun 25, 2009 Plug Power Inc. (Nasdaq:PLUG) closed at $0.80 on a volume of 560,172 shares.
Department of Defense Purchases 19 GenDrive Power Units From Plug Power
LATHAM, N.Y., Jun 26, 2009 -- Plug Power Inc. (Nasdaq:PLUG), a leader in providing clean, reliable energy solutions, today announced it has been selected to provide 19 class 1 GenDrive fuel cell power units and two years of managed services for a demonstration project funded by the Department of Defense (DoD). Plug Power's GenDrive units will be commissioned at the U.S. Army's Forces Command in Fort Lewis, Washington where they will power a fleet of sit-down counterbalanced lift trucks.
About Plug Power Inc.
Plug Power Inc. (Nasdaq:PLUG), an established leader in the development and deployment of clean, reliable energy solutions, integrates fuel cell technology into motive, continuous and backup power products. The Company is actively engaged with private and public customers in targeted markets throughout the world. For more information about how to join Plug Power's energy revolution as an investor, customer, supplier or strategic partner, please visit www.plugpower.com.
-- Jun 25, 2009 Garmin Ltd. (NASDAQ: GRMN | Quote | Chart | News | PowerRating) closed at $22.67 on a volume of 4,648,361 shares.
Garmin(R) Announces Dakota(TM) Touchscreen Outdoor Handhelds, Simple to Use and Simple to Afford
OLATHE, Kan., Jun 26, 2009 -- Garmin International Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), the global leader in satellite navigation, today announced the Dakota 10 and Dakota 20 handheld GPS navigators, packing a high-sensitivity GPS receiver, worldwide basemap and color touchscreen display into a compact, waterproof device with up to 20 hours of battery life.
About Garmin International Inc.
Garmin International Inc. is a subsidiary of Garmin Ltd. (Nasdaq: GRMN), the global leader in satellite navigation. Since 1989, this group of companies has designed, manufactured, marketed and sold navigation, communication and information devices and applications - most of which are enabled by GPS technology. Garmin's products serve automotive, mobile, wireless, outdoor recreation, marine, aviation, and OEM applications. Garmin Ltd. is incorporated in the Cayman Islands, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. For more information, visit Garmin's virtual pressroom at www.garmin.com/pressroom or contact the Media Relations department at 913-397-8200. Garmin, Foretrex and Oregon are registered trademarks and Dakota, Colorado and HotFix are trademarks of Garmin Ltd. or its subsidiaries.
About PennyStockChaser.com
PennyStockChaser.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, new 52 weeks high or lows, stocks with technical indicators and much more. Our stock alerts have done very well in the last couple of weeks.
PennyStockChaser.com is a leading stock website that provides free daily alerts on stocks that are moving up. PennyStockChaser.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at editorial@pennystockchaser.com
PennyStockChaser.com is an independent electronic publication that provides information on selected publicly traded companies. PennyStockChaser.com is not a registered investment advisor or broker-dealer. PennyStockChaser.com's affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: Editorial Staff, PennyStockChaser e-mail: editorial@pennystockchaser.com WWW: http://www.pennystockchaser.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
